Dural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI/bevacizumab

dc.authoridÖzen, Alaattin/0000-0001-9219-6001
dc.authoridÖzen, Alaattin/0000-0001-9219-6001
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authorwosidÖzen, Alaattin/ABG-9988-2020
dc.authorwosidÖzen, Alaattin/IZQ-0388-2023
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.contributor.authorOzen, Alaattin
dc.contributor.authorCicin, Irfan
dc.contributor.authorSezer, Atakan
dc.contributor.authorUzunoglu, Sernaz
dc.contributor.authorSaynak, Mert
dc.contributor.authorGenchellac, Hakan
dc.contributor.authorKaragol, Hakan
dc.date.accessioned2024-06-12T10:54:26Z
dc.date.available2024-06-12T10:54:26Z
dc.date.issued2009
dc.departmentTrakya Üniversitesien_US
dc.description.abstractThe adverse effects of regimes in cancer treatment have forced us to change to new targeted therapy options. Understanding these side effects, which can lead to discontinuation of the new therapy strategies, will allow the clinical management of these side effects and result in continuing therapies with effective medications. Bevacizumab, which is an IgG1 antibody against vascular endothelial growth factor, has side effects such as proteinuria, hypertension, venous and arterial thromboembolic events, and hemorrhage. This is the first reported case of dural sinus vein thrombosis, during the treatment with bevacizumab.en_US
dc.identifier.doi10.4103/0973-1482.52791
dc.identifier.endpage132en_US
dc.identifier.issn0973-1482
dc.identifier.issn1998-4138
dc.identifier.issue2en_US
dc.identifier.pmid19542672en_US
dc.identifier.scopus2-s2.0-67749098105en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage130en_US
dc.identifier.urihttps://doi.org/10.4103/0973-1482.52791
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19052
dc.identifier.volume5en_US
dc.identifier.wosWOS:000267145100014en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofJournal Of Cancer Research And Therapeuticsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBevacizumaben_US
dc.subjectDural Sinus Veinen_US
dc.subjectThrombosisen_US
dc.subjectMetastatic Colorectal-Canceren_US
dc.subjectBevacizumaben_US
dc.subjectFluorouracilen_US
dc.subjectLeucovorinen_US
dc.titleDural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI/bevacizumaben_US
dc.typeArticleen_US

Dosyalar